Institutional
First Turn Management, LLC
CIK 0001993440
$895.1M
Reported AUM
33
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · First Turn Management, LLC · Q1 2026
AI · grounded in 13F
First Turn Management, LLC closed its position in GH for a reduction of $27.7M. The fund established several new positions, including ELVN for $24.5M and CELC for $24.0M. Additionally, the fund accumulated shares of UTHR, increasing its position by 64.7%.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP DEL | $527.00 | 0.44% | 76.90% | 142.27% | $62.1M | 6.94% | — | HELD |
| 2 | ABVX | ABIVAX SA | $121.03 | 1.84% | 65.18% | 1070.84% | $51.9M | 5.80% | — | HELD |
| 3 | BBIO | BRIDGEBIO PHARMA INC | $81.47 | -2.47% | 77.69% | 67.97% | $51.7M | 5.77% | — | HELD |
| 4 | XENE | XENON PHARMACEUTICALS INC | $62.73 | -0.59% | 106.89% | 257.51% | $45.8M | 5.11% | — | HELD |
| 5 | RVMD | REVOLUTION MEDICINES INC | $184.47 | 1.96% | 393.91% | 521.93% | $45.5M | 5.09% | — | HELD |
| 6 | APGE | APOGEE THERAPEUTICS INC | $134.15 | -0.04% | 255.36% | 484.79% | $43.2M | 4.83% | — | HELD |
| 7 | INSM | INSMED INC | $101.53 | -1.54% | -3.85% | 272.72% | $40.6M | 4.54% | — | HELD |
| 8 | NUVL | NUVALENT INC | — | — | 0.00% | — | $37.9M | 4.24% | — | HELD |
| 9 | MIRM | MIRUM PHARMACEUTICALS INC | $108.04 | 0.44% | 106.79% | 561.97% | $37.0M | 4.13% | — | HELD |
| 10 | COGT | COGENT BIOSCIENCES INC | $39.89 | 0.81% | 247.33% | 378.21% | $36.5M | 4.07% | — | HELD |
| 11 | ROIV | ROIVANT SCIENCES LTD | $33.24 | 1.13% | 196.20% | 236.68% | $33.0M | 3.68% | — | HELD |
| 12 | AXSM | AXSOME THERAPEUTICS INC. | $230.01 | 1.14% | 121.03% | 782.79% | $31.9M | 3.56% | — | HELD |
| 13 | IDYA | IDEAYA BIOSCIENCES INC | $35.67 | 0.22% | 46.64% | 51.45% | $29.1M | 3.25% | — | HELD |
| 14 | ORIC | ORIC PHARMACEUTICALS INC | $11.19 | -0.81% | 11.46% | -48.94% | $25.6M | 2.86% | — | HELD |
| 15 | ELVN | ENLIVEN THERAPEUTICS INC | $53.06 | 0.17% | 182.81% | 176.46% | $24.5M | 2.73% | — | HELD |
| 16 | CELC | CELCUITY INC | $84.16 | 1.08% | 108.62% | 278.45% | $24.0M | 2.69% | — | HELD |
| 17 | SRRK | SCHOLAR ROCK HLDG CORP | $49.17 | 0.21% | 34.93% | 24.11% | $21.9M | 2.45% | — | HELD |
| 18 | KYMR | KYMERA THERAPEUTICS INC | $104.75 | -0.48% | 143.32% | 68.22% | $21.2M | 2.37% | — | HELD |
| 19 | CYTK | CYTOKINETICS INC | $79.22 | 1.06% | 115.51% | 139.82% | $18.7M | 2.09% | — | HELD |
| 20 | DNTH | DIANTHUS THERAPEUTICS INC | $106.75 | 2.56% | 405.54% | 1.65% | $18.5M | 2.07% | — | HELD |
| 21 | PVLA | PALVELLA THERAPEUTICS INC NE | $145.90 | 2.31% | 283.01% | -67.53% | $18.5M | 2.06% | — | HELD |
| 22 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $27.30 | -2.19% | 31.16% | 188.92% | $17.9M | 2.00% | — | HELD |
| 23 | VRDN | VIRIDIAN THERAPEUTICS INC | $19.40 | -2.44% | 14.19% | 48.58% | $17.8M | 1.99% | — | HELD |
| 24 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $17.5M | 1.95% | — | HELD |
| 25 | FULC | FULCRUM THERAPEUTICS INC | $3.66 | 1.10% | -47.00% | -87.81% | $17.3M | 1.93% | — | HELD |
| 26 | 430 | TERNS PHARMACEUTICALS INC | — | — | — | — | $17.2M | 1.92% | — | HELD |
| 27 | VERA | VERA THERAPEUTICS INC | $32.88 | 1.14% | 55.85% | 121.51% | $17.0M | 1.90% | — | HELD |
| 28 | NTRA | NATERA INC | $255.96 | 0.84% | 88.60% | 114.32% | $16.2M | 1.81% | — | HELD |
| 29 | ERAS | ERASCA INC | $18.01 | 1.64% | 1174.82% | -25.89% | $14.0M | 1.57% | — | HELD |
| 30 | PRAX | PRAXIS PRECISION MEDICINES I | $302.37 | 3.90% | 451.22% | 0.04% | $13.7M | 1.53% | — | HELD |
| 31 | OLMA | OLEMA PHARMACEUTICALS INC | $11.12 | -0.63% | — | — | $11.5M | 1.28% | — | HELD |
| 32 | QURE | UNIQURE NV | $41.35 | 3.19% | — | — | $10.1M | 1.12% | — | HELD |
| 33 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $18.54 | 0.87% | — | — | $5.9M | 0.66% | — | HELD |
Source: SEC EDGAR · accession 0001993440-26-000002. 13F discloses long positions only — shorts, foreign equities, and options are excluded.